Synthetic biology is one of the most rapidly growing segments at Biomax. Cost-effective DNA sequencing and de novo DNA synthesis have facilitated the emergence and rapid evolution of synthetic biology.
The development of DNA assembly standards, publicly available parts registers for sharing bioparts and computer-aided design (CAD) tools have been instrumental in accelerating discovery.
Biomax synthetic biology solutions address the challenges of putting this innovation to good use. With enterprise-level knowledge management platforms that empower new and emerging molecular technologies, Biomax helps clients meet the challenges of R&D process efficiency and productivity in many areas: